Earnings Preview: AptarGroup (ATR) Q3 Earnings Expected to Decline

AptarGroup (ATR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Investment Research • Oct 22, 2026

AptarGroup (ATR) Loses 5.9% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

AptarGroup (ATR) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.

Zacks Investment Research • Oct 5, 2026

ExxonMobil, Visa Among 16 Dividend Growth Companies To Announce Annual Dividend Increases In October

ExxonMobil is expected to announce its 45th consecutive year of dividend growth in October, with a predicted increase of 4.4–5.8%. XOM's cost-cutting and share buybacks are driving a recovery, with GAAP EPS up 26% and adjusted EPS up 32% in 1H 2026. Dividend growth for XOM is forecast to accelerate modestly, reflecting improved earnings after a period of slower growth and recent acquisitions.

Seeking Alpha • Oct 5, 2026

3 Packaging Stocks Worth Watching Despite Industry Pressure

Although weak demand and tariffs cloud the Zacks Containers - Paper and Packaging industry's near-term outlook, AVY, ATR and KRT are navigating the challenges well.

Zacks Investment Research • Sep 25, 2026

AptarGroup, Inc. (ATR) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript

AptarGroup, Inc. (ATR) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript

Seeking Alpha • Sep 15, 2026

AptarGroup, Inc. (ATR) Presents at Wells Fargo 21st Annual Healthcare Conference Transcript

AptarGroup, Inc. (ATR) Presents at Wells Fargo 21st Annual Healthcare Conference Transcript

Seeking Alpha • Sep 9, 2026

Dividend Champion, Contender, And Challenger Highlights: Week August 16

A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Companies which changed their dividends. Companies with upcoming ex-dividend dates.

Seeking Alpha • Aug 14, 2026

AptarGroup Q2 Earnings Beat Estimates on Pharma & Beverage Growth

ATR tops Q2 earnings and revenue estimates as pharma and beverage growth lift quarterly revenues above $1B for the first time despite margin pressure.

Zacks Investment Research • Aug 5, 2026

Why AptarGroup (ATR) International Revenue Trends Deserve Your Attention

Review AptarGroup's (ATR) international revenue performance and how it affects the predictions of financial analysts on Wall Street and the future prospects for the stock.

Zacks Investment Research • Aug 3, 2026

AptarGroup Q2 Earnings Call Highlights

AptarGroup NYSE: ATR reported second-quarter sales growth across each of its three segments and adjusted earnings per share above its guidance range, supported by stronger-than-expected performance in its Pharma business. The company also said President and CEO Stephan Tanda will retire later this year, with President and CEO Designate Gael Touya set to assume the CEO role on Sept.

MarketBeat • Jul 31, 2026